Current unmet needs in locally advanced (unresectable) or metastatic dedifferentiated liposarcoma, the relevance of progression-free survival as clinical endpoint, and expectations for future clinical trial design: an international Delphi consensus report.
Nom du journal : ESMO Open
Année : 2024
Volume : 9
Page de départ : 103487
